Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Raw Materials (2016 - 2025)

Amphastar Pharmaceuticals has reported Raw Materials over the past 11 years, most recently at $106.8 million for Q4 2025.

  • Quarterly results put Raw Materials at $106.8 million for Q4 2025, up 31.06% from a year ago — trailing twelve months through Dec 2025 was $106.8 million (up 31.06% YoY), and the annual figure for FY2025 was $106.8 million, up 31.06%.
  • Raw Materials for Q4 2025 was $106.8 million at Amphastar Pharmaceuticals, up from $105.8 million in the prior quarter.
  • Over the last five years, Raw Materials for AMPH hit a ceiling of $106.8 million in Q4 2025 and a floor of $40.4 million in Q1 2022.
  • Median Raw Materials over the past 5 years was $49.0 million (2023), compared with a mean of $61.2 million.
  • Biggest five-year swings in Raw Materials: dropped 20.63% in 2021 and later skyrocketed 100.84% in 2025.
  • Amphastar Pharmaceuticals' Raw Materials stood at $41.9 million in 2021, then rose by 13.75% to $47.6 million in 2022, then increased by 5.2% to $50.1 million in 2023, then surged by 62.76% to $81.5 million in 2024, then soared by 31.06% to $106.8 million in 2025.
  • The last three reported values for Raw Materials were $106.8 million (Q4 2025), $105.8 million (Q3 2025), and $106.5 million (Q2 2025) per Business Quant data.